These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11488208)

  • 21. New drug overview. Celecoxib.
    Am J Health Syst Pharm; 1999 May; 56(10):1031. PubMed ID: 10365731
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs.
    Zhao SZ; Wentworth C; Burke TA; Makuch RW
    Pharmacoepidemiol Drug Saf; 2004 May; 13(5):277-87. PubMed ID: 15133778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The pharmacological effect of nonsteroid anti-inflammatory agents and their interaction with blood plasma proteins].
    Lutsevich AN; Bender KI; Kupchikov VV
    Eksp Klin Farmakol; 1992; 55(2):68-74. PubMed ID: 1422462
    [No Abstract]   [Full Text] [Related]  

  • 24. Celecoxib--a rational alternative to NSAIDs.
    Moodley I; Hirsch G
    S Afr Med J; 2001 Jan; 91(1):36-40. PubMed ID: 11236293
    [No Abstract]   [Full Text] [Related]  

  • 25. [Mobility and quality of life for arthrosis and rheumatism patients. Modern pain management with selective cox-2 inhibition].
    MMW Fortschr Med; 2002 Jul; 144(29-30):52. PubMed ID: 12219613
    [No Abstract]   [Full Text] [Related]  

  • 26. [Celecoxib in the symptomatic treatment of active osteo- or rheumatoid arthritis. Results of a post-marketing surveillance].
    Wigand R; Wehling M; Brauer HG; Stridde E; Vergin H; May M
    Dtsch Med Wochenschr; 2004 May; 129(21):1188-92. PubMed ID: 15160322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Selective Cox-2 inhibitor in osteoarthritis and rheumatoid arthritis. No increased risk for the heart].
    MMW Fortschr Med; 2003 Mar; 145(11):60. PubMed ID: 12688204
    [No Abstract]   [Full Text] [Related]  

  • 28. Celecoxib in osteoarthritis and rheumatoid arthritis: new preparation. As disappointing as rofecoxib.
    Prescrire Int; 2001 Apr; 10(52):46-9. PubMed ID: 11718158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-hyperalgesic effects of nimesulide: studies in rats and humans.
    Bianchi M; Broggini M
    Int J Clin Pract Suppl; 2002 Jul; (128):11-9. PubMed ID: 12166613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-inflammatory drugs fall short in Alzheimer's disease.
    Nat Med; 2008 Sep; 14(9):916. PubMed ID: 18776882
    [No Abstract]   [Full Text] [Related]  

  • 31. Celebrex approved for juvenile arthritis.
    FDA Consum; 2007; 41(2):3. PubMed ID: 17590891
    [No Abstract]   [Full Text] [Related]  

  • 32. [Celecoxib and the CLASS study--worse and worse...].
    Slørdal L
    Tidsskr Nor Laegeforen; 2002 Sep; 122(22):2219. PubMed ID: 12426903
    [No Abstract]   [Full Text] [Related]  

  • 33. Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practice.
    Wolfe F; Michaud K; Burke TA; Zhao SZ
    J Rheumatol; 2004 Feb; 31(2):355-8. PubMed ID: 14760808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [When the cardiac patient with arthritis needs aspirin and NSAID: how to protect the stomach?].
    Zeidler H
    MMW Fortschr Med; 2003 Jan; 145(5):8. PubMed ID: 12619198
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cox-2 inhibitors in the focus. Rofecoxib as effective as the "classics"].
    MMW Fortschr Med; 2001 Nov; 143(46):50-1. PubMed ID: 11759601
    [No Abstract]   [Full Text] [Related]  

  • 36. Nonsteroidal anti-inflammatory drugs in the elderly.
    Buffum M; Buffum JC
    Pain Manag Nurs; 2000 Jun; 1(2):40-50. PubMed ID: 11706458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimutagenic and anti-oxidant activities of the non-steroidal anti-inflammatory drug celecoxib.
    Ajith T; Subin JP; Jacob J; Sanjay PS; Babitha NV
    Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):888-93. PubMed ID: 16173952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors.
    Kusunoki N; Yamazaki R; Kawai S
    Arthritis Rheum; 2002 Dec; 46(12):3159-67. PubMed ID: 12483719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Celecoxib].
    Fux R; Mörike K; Gleiter CH
    Dtsch Med Wochenschr; 2002 Apr; 127(15):803-4. PubMed ID: 11951138
    [No Abstract]   [Full Text] [Related]  

  • 40. The anti-proliferative potency of celecoxib is not a class effect of coxibs.
    Schiffmann S; Maier TJ; Wobst I; Janssen A; Corban-Wilhelm H; Angioni C; Geisslinger G; Grösch S
    Biochem Pharmacol; 2008 Jul; 76(2):179-87. PubMed ID: 18547544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.